INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Clinical trial NCT03491683 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03491683
- Sponsor
- Inovio Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2026-12-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.